Global Introduction of New Multidrug-Resistant Tuberculosis Drugs—Balancing Regulation with Urgent Patient Needs
Author:
Publisher
Centers for Disease Control and Prevention (CDC)
Subject
Infectious Diseases,Microbiology (medical),Epidemiology
Reference42 articles.
1. Global tuberculosis report. Geneva: World Health Organization; 2014.
2. The diarylquinoline TMC207 for multidrug-resistant tuberculosis.;Diacon;N Engl J Med,2009
3. Delamanid for multidrug-resistant pulmonary tuberculosis.;Gler;N Engl J Med,2012
4. Advances in the development of new tuberculosis drugs and treatment regimens.;Zumla;Nat Rev Drug Discov,2013
5. New antituberculosis drugs, regimens, and adjunct therapies: needs, advances, and future prospects.;Zumla;Lancet Infect Dis,2014
Cited by 16 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Computational analysis of RNA methyltransferase Rv3366 as a potential drug target for combating drug-resistant Mycobacterium tuberculosis;Frontiers in Molecular Biosciences;2024-01-11
2. Nyctanthes arbor-tristis L.: Perspective of phytochemical-based inhibition of fatty acid biosynthesis in Mycobacterium tuberculosis;International Journal of Plant Based Pharmaceuticals;2022-03-04
3. Market Formation in a Global Health Transition;Environmental Innovation and Societal Transitions;2021-09
4. To what extent are the antimalarial markets in African countries ready for a transition to triple artemisinin-based combination therapies?;PLOS ONE;2021-08-31
5. Developing Synergistic Drug Combinations To Restore Antibiotic Sensitivity in Drug-Resistant Mycobacterium tuberculosis;Antimicrobial Agents and Chemotherapy;2021-04-19
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3